Moneycontrol Podcast / Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

Our new player has been redesigned to fit in better wherever you embed it. Feedback is welcome on our support site.
You can still use our old player if you prefer.